Vanguard Group Inc Spruce Biosciences, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Spruce Biosciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 843,844 shares of SPRB stock, worth $430,360. This represents 0.0% of its overall portfolio holdings.
Number of Shares
843,844
Previous 863,375
2.26%
Holding current value
$430,360
Previous $448,000
11.61%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding SPRB
# of Institutions
39Shares Held
16.6MCall Options Held
26.9KPut Options Held
59.3K-
River Vest Venture Management LLC St. Louis, MO2.94MShares$1.5 Million20.39% of portfolio
-
Carlyle Group Inc. Washington, DC2.9MShares$1.48 Million0.2% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.61MShares$1.33 Million0.04% of portfolio
-
Abingworth LLP London, X01.79MShares$914,1840.65% of portfolio
-
Acadian Asset Management LLC Boston, MA1.26MShares$642,1670.0% of portfolio
About SPRUCE BIOSCIENCES, INC.
- Ticker SPRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,560,200
- Market Cap $12M
- Description
- Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...